Jose (pepe) Calle Gordo BSc

Jose (Pepe) Calle Gordo brings 30 years of business and management experience in the medical device industry and serves on the Board of Lungpacer, FEops, JenaValve, and Laminate.

Pepe joined Valiance from Singapore-based Biosensors where he most recently served as Vice Chairman of the Board of Directors. Pepe started his tenure at Biosensors as Executive Director and CEO. He performed a turn-around of the Company’s operating performance, forged strategic alliances, and worked with the largest shareholder to successfully privatize and de-list the company in order to create a global player in interventional cardiology valued at over $1 billion. Pepe joined Biosensors from Abbott where he was Vice President of Abbott Vascular and led the global commercial introduction of MitraClip, a percutaneous treatment for mitral valve repair. Prior to Abbott, he served as Vice President and General Manager of Drug Eluting Stents at Guidant based in California. He started his career at Eli Lily in London.

Pepe holds a BSc in Biomedical and Electrical engineering from the Universidad Politecnica de Madrid, Spain.